Network-based Drug Repurposing: A Critical Review.

Area of Science:

• Computational biology
• Pharmacology
• Bioinformatics

Background:

• Developing new drugs is costly, time-consuming, and has a low success rate.
• Repurposing existing drugs offers a more efficient approach, saving time and resources.
• Identifying suitable drugs for repurposing is challenging due to vast, complex data.

Purpose of the Study:

• To review computational biological network analysis methods for drug repurposing.
• To highlight the integration of diverse datasets for enhanced drug repurposing efficiency.
• To discuss limitations, prediction methodologies, and datasets used in biological networks for drug repurposing.

Main Methods:

• Exploration of various network analysis types: gene regulatory, metabolic, protein-protein interaction, drug-target, drug-disease, drug-drug, and drug-side effects networks.
• Discussion of integrated network-based methods, semantic link networks, and isoform-isoform networks.
• Review of available datasets including gene expression, electronic health records, and clinical trial results.

Main Results:

• Computational methods, particularly network analysis, simplify complex biological and pharmacological data.
• Integration of multiple datasets and analysis methods enhances the efficiency and accuracy of drug repurposing.
• Network analysis facilitates the identification of drugs for specific targets and desired effects.

Conclusions:

• Computational network analysis is crucial for overcoming limitations in drug repurposing.
• Integrating diverse biological datasets and network analysis methods streamlines the identification of effective drug repurposing candidates.
• This approach significantly improves the success rate, reduces costs, and accelerates the drug repurposing process.